Related Experiment Video
Updated: Oct 2, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
[The surgical experiences and risk factors of combined valvular procedure and myocardial revascularization]
1Department of Cardiovascular Surgery, Fu Wai Hospital, PUMC & CAMS, 100037, China.
Insights
Combined valve surgery and coronary artery bypass grafting (CABG) can improve heart function but increases operative mortality. Key success factors include complete revascularization and effective myocardial protection.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Surgery
- Coronary Artery Bypass Grafting
Context:
- The study examines the combined procedure of valve surgery and CABG.
- A cohort of 76 patients (61 men, 15 women; mean age 56) underwent this combined procedure.
- The primary etiologies were rheumatic disease (67 patients) and degenerative valve disease (9 patients).
Purpose:
- To report the experience and outcomes of combined valve procedures and CABG.
- To analyze risk factors associated with operative mortality in this patient group.
Summary:
- The combined procedure involved various valve interventions (AVR, MVR, BVR, MVP) alongside CABG.
- Operative mortality was 7.89% (6 deaths).
- Follow-up in 63 survivors showed significant improvement in cardiac function for 62 patients.
Impact:
- Combined valve replacement/repair with CABG generally increases operative mortality.
- Preoperative myocardial infarction, NYHA class IV, lower ejection fraction (EF), and longer cardiopulmonary bypass (CPB) and aortic clamping times are linked to hospital mortality.
- Successful outcomes depend on complete grafting of coronary lesions, restored valvular function, and robust myocardial protection.
Objective:
To introduce the experience of combined valve procedure and CABG.
Methods:
61 men and 15 women, with a mean age of 56 years, underwent combined valve procedure and CABG. CABG was performed with AVR (1 - 3 grafts) in 25 patients, with MVR (1 - 4 grafts) in 31 (MVR + AVP in 2, MVR + TVP in 3), with aortic and mitral valve replacement (1 - 3 grafts) in 18 (BVR + TVP in 2), with MVP (1 graft) in 1 and with MVP + TVP (1 graft) in 1 patient. Rheumatic disease was present in 67 and degenerative aortic and mitral valve disease was present in 9. SPSS statistical software was used to analyse the risk factors of the operation.
Results:
6 operative deaths (7.89%) occurred. 63 patients (63/70) who survived the operation were followed up for a mean period of 26.8 months. The function of heart in 62 patients was significantly improved. One patient died of SBE 9 months after operation.
Conclusion:
The combination of valve replacement or repair with coronary revascularization generally increases operative mortality. The hospital mortality is related to preoperative myocardial infarction, NYHA class IV, lower EF and the longer time of CPB and clamping aorta. Grafting in all significant coronary lesions, restoration of valvular function and good myocardial protection are the key factors for the success of CABG with valvular procedure.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation III: Medical Management

